- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Joseph Kvedar Discusses Wearables and the Patient-Insurer Relationship
How new technologies like mHealth and wearables may affect insurance providers and patient costs, according to Joseph C. Kvedar, MD, vice president of Connected Health at Partners HealthCare.
How new technologies like mHealth and wearables may affect insurance providers and patient costs, according to Joseph C. Kvedar, MD, vice president of Connected Health at Partners HealthCare.
Transcript (modified)
How will mHealth and wearables change the patient-insurer relationship?
Well the most interesting example of that is a firm called Oscar, which you might be aware of. It’s a new, innovative insurer and they’ve set up a program where if people wear an “activity tracker,” they can get credit on their premium cost for being more active. I expected to see that happen. Progressive Insurance, which is an auto insurance company, has a program where if you put a sensor on your car and you drive safely, they’ll give you premium credits. So I expect more and more of that to happen in the insurance industry.
Maybe what you’ll see in the next few years is a bit of a divergence because the focus will be on healthcare providers who monitor things like blood pressure and diabetes, and these insurers may take up the improvement in health with their employer colleagues. That would make some sense because there are wearables that fit both categories now.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
